$0.49
-0.04(-7.48%)
Mkt Cap $69M
$0.38
$0.92
52-Week Range
At a Glance
AI-generatedXtant Medical achieved profitability with revenue up 14.2% to $133.9M and operating income swinging to $7.3M from a $12.1M loss, driven by gross margin expansion to 62.9% and operating expense discipline amid favorable revenue mix.
Revenue breakdown: Product (45.9%), Orthobiologics (27.7%), Spinal Implant (18.2%).
8-K
Xtant Medical Holdings, Inc. reported Q4 and full-year 2025 financial results with revenue of $32.4M and $134.0M respectively, achieving net income of $5.0M and adjusted EBITDA of $16.3M, alongside divestiture proceeds and 2026 revenue guidance of $95-99M.$69M
Market Cap
—
Revenue
—
Net Income
Employees217
Fundamentals
How The Business Makes Money
Revenue by Segment
Product45.9%($231M)
Orthobiologics27.7%($139M)
Spinal Implant18.2%($92M)
License4%($20M)
License Revenue4%($20M)
Bill And Hold Transactions0.1%($400.0K)
Revenue by Geography
US90.8%($228M)
Non Us9.2%($23M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001453593
ISINUS98420P3082
CUSIP98420P308
Phone406 388 0480
Address664 Cruiser Lane, Belgrade, MT, 59714, US
SEC EDGAR